Skip to content
Search

Latest Stories

Millenium Pharmacy owner takes over high-dispensing Wigan pharmacy

Millenium Pharmacy owner takes over high-dispensing Wigan pharmacy

The deal was struck in under eight weeks after the former owner decided to sell it to pursue a well-earned retirement

J England Pharmacy Limited in Wigan, Greater Manchester, has been sold to Stuart Ellis, the owner of Millenium Pharmacy in St.Helens, following a confidential sales process, Christie & Co announced on Wednesday.


The community pharmacy, located on Gidlow Lane, adjoining Beech Hill Medical Practice, dispenses an average of 17,678 items per month, according to the specialist business property adviser.

It was established in the early 1960s by Doug England, who handed over the business to his son, Warren, in 1995.

Former owner Warren England recently decided to sell the high-dispensing pharmacy for the first time to pursue a “well-earned retirement.”

Commenting on the sale of J England Pharmacy, Warren said: “I am pleased that the legacy of the pharmacy business that my father founded in the 1960s has been passed on to such a safe pair of hands in the shape of Stuart. I wish him and his team the very greatest of success.”

New owner, Stuart, who also runs an aesthetics supply business at his previous community pharmacy, now plans to make full use of the location and position of both pharmacies to grow the services offering and enhance the brand profile.

Stuart commented, “I am hugely excited to be taking over J England Pharmacy. My interest in community pharmacy began at the age of 14 when I was working at a long-established family-owned pharmacy business, and so it is an honour to take on the legacy of this similar business which aligns with my own long-held values and beliefs around community pharmacy. I’d like to thank Warren for his openness throughout the process and wish him a very happy retirement.”

Jon Booth, Director – Pharmacy at Christie & Co informed that the deal was struck in under eight weeks, with funding sourced through David Ward at Christie Finance. However, they didn’t reveal the value of the deal.

 

 

 

More For You

RPS Wales calls for urgent investment in pharmacy workforce at Senedd meeting

Third from the left: Eluned Morgan, First Minister of Wales

Photo credit: RPS

Invest in pharmacy workforce: RPS Wales urges Senedd members

Members of the Senedd (MSs) were briefed on the increasing pressures facing pharmacy teams and the urgent need for action to support their health and wellbeing at an event hosted by the Royal Pharmaceutical Society (RPS) Wales.

The event, held on Wednesday, brought together MSs, including first minister Eluned Morgan, to discuss the findings of RPS’ latest Workforce Wellbeing Survey.

Keep ReadingShow less
Imported dengue reach record high, warns UKSHA

Most dengue cases were linked to travel to Southern and South-Eastern Asia.

Getty Images

Imported dengue cases hit record high – Consult your pharmacist before you travel

The UK Health Security Agency (UKSHA) has warned that imported dengue cases in England, Wales, and Northern Ireland (EWNI) have reached their highest level since dengue surveillance began in 2009.

New data from the agency reveals that 904 dengue cases were reported among returning travellers in these countries in 2024, a sharp increase from 631 in 2023.

Keep ReadingShow less
Henry Gregg named as new NPA chief executive

Henry Gregg (left) with Sir Chris Whitty

Pic credit: Henry Gregg/X

Henry Gregg named as new NPA chief executive

The National Pharmacy Association (NPA) has announced Henry Gregg will be the organisation’s new chief executive from May.

Gregg, who is currently director of external affairs at Asthma + Lung UK, replaces Paul Rees who departed in January.

Keep ReadingShow less
Kelso Pharma continues expansion with £140M funding boost

Kelso Pharma will use the funds to support further acquisitions and expand in the UK and Europe.

Getty Images

Kelso Pharma secures over £140m of acquisition funding

Kelso Pharma has secured more than £140 million of acquisition funding to support its expansion in the UK and across Europe.

The specialty pharmaceuticals business today (27) confirmed that a proportion of the funding was used for its acquisition of ALTURiX last month, a deal that doubled the size of the company’s UK business.

Keep ReadingShow less
Community pharmacist accessing GP Connect Access Record on Cegedim Rx platform

GP Connect Access Record will make a patient’s relevant medical information available to pharmacy.

Getty Images

Cegedim Rx activates GP Connect Access Record

Community pharmacy IT supplier Cegedim Rx has made GP Connect Access Record functionality available across its clinical services platform, providing registered pharmacy professionals with enhanced access to patient medical information.

The new feature, now live on Cegedim Rx’s Pharmacy Services platform, allows community pharmacies to retrieve relevant medical data when delivering NHS clinical services.

Keep ReadingShow less